Overview

butyrylcholinesterase


Related Overviews

 

'butyrylcholinesterase' can also refer to...

butyrylcholinesterase

Targeting acetylcholinesterase and butyrylcholinesterase in dementia

Predicting outcome using butyrylcholinesterase activity in organophosphorus pesticide self-poisoning

Prophylaxis against Soman Inhalation Toxicity in Guinea Pigs by Pretreatment Alone with Human Serum Butyrylcholinesterase

Determinants of Butyrylcholinesterase Inhibition Among Agricultural Pesticide Handlers in Washington State: An Update

Awareness during emergence from anaesthesia: significance of neuromuscular monitoring in patients with butyrylcholinesterase deficiency

Premature awakening and underuse of neuromuscular monitoring in a registry of patients with butyrylcholinesterase deficiency

Quantification of Nerve Agent VX-Butyrylcholinesterase Adduct Biomarker from an Accidental Exposure

Analysis of the Butyrylcholinesterase Gene and Nearby Chromosome 3 Markers in Alzheimer Disease

No Association Between the K Variant of the Butyrylcholinesterase Gene and Pathologically Confirmed Alzheimer's Disease

Estimation of the Upper Limit of Human Butyrylcholinesterase Dose Required for Protection against Organophosphates Toxicity: a Mathematically Based Toxicokinetic Model

Aging Pathways for Organophosphate-Inhibited Human Butyrylcholinesterase, Including Novel Pathways for Isomalathion, Resolved by Mass Spectrometry

Inhibition of Human Plasma and Serum Butyrylcholinesterase (EC 3.1.1.8) by α-Chaconine and α-Solanine

Reactivation of Plasma Butyrylcholinesterase by Pralidoxime Chloride in Patients Poisoned by WHO Class II Toxicity Organophosphorus Insecticides

Reactivation of Plasma Butyrylcholinesterase by Pralidoxime Chloride in Patients Poisoned by WHO Class II Toxicity Organophosphorus Insecticides

Plasma Butyrylcholinesterase as a Marker of Clinical Outcome in Diethyl Organophosphorus Insecticide Poisoned Patients Treated With Pralidoxime

GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors

Verification of Exposure to Cholinesterase Inhibitors: Generic Detection of OPCW Schedule 1 Nerve Agent Adducts to Human Butyrylcholinesterase

Synergy Between the Genes for Butyrylcholinesterase K Variant and Apolipoprotein E4 in Late-Onset Confirmed Alzheimer's Disease

 

More Like This

Show all results sharing this subject:

  • Medicine and Health

GO

Show Summary Details

Quick Reference

A family of enzymes (BChE, choline esterase II, pseudocholinesterase, EC 3.1.1.8, 602 aa), produced mainly in the liver, that hydrolyse esters such as procaine and suxamethonium. There are several variants, dependent on four alleles, with different enzymatic activity; the variants that are expressed determine sensitivity to suxamethonium. Defects in the enzyme cause butyrylcholinesterase deficiency, an autosomal recessive metabolic disorder in which there is prolonged apnoea after the use of certain anesthetic drugs, including the muscle relaxant succinylcholine.

Subjects: Medicine and Health.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.